Can-Fite BioPharma Ltd. Quarterly Liabilities and Equity in USD from Q4 2018 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Can-Fite BioPharma Ltd. quarterly Liabilities and Equity history and growth rate from Q4 2018 to Q4 2024.
  • Can-Fite BioPharma Ltd. Liabilities and Equity for the quarter ending December 31, 2024 was $9.12M, a 8.7% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $9.12M -$869K -8.7% Dec 31, 2024 20-F 2025-04-14
Q2 2024 $5.92M -$5.11M -46.3% Jun 30, 2024 6-K 2024-08-29
Q4 2023 $9.99M +$706K +7.61% Dec 31, 2023 20-F 2025-04-14
Q2 2023 $11M -$3.71M -25.2% Jun 30, 2023 6-K 2023-08-31
Q4 2022 $9.28M -$11M -54.2% Dec 31, 2022 20-F 2024-03-28
Q2 2022 $14.7M +$5.07M +52.3% Jun 30, 2022 6-K 2022-08-25
Q4 2021 $20.3M +$10.7M +113% Dec 31, 2021 20-F 2023-03-30
Q2 2021 $9.68M -$3.12M -24.4% Jun 30, 2021 6-K 2021-08-26
Q4 2020 $9.52M +$1.35M +16.5% Dec 31, 2020 20-F 2022-03-24
Q2 2020 $12.8M Jun 30, 2020 6-K 2020-08-27
Q4 2019 $8.17M +$222K +2.79% Dec 31, 2019 20-F 2021-03-25
Q4 2018 $7.95M Dec 31, 2018 6-K 2020-06-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.